Publication | Open Access

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

VaccinationCancer ImmunosurveillanceHigh-risk Melanoma PatientsPolyfunctional T CellsImmunologyTumor ImmunityImmunodominanceTherapeutic VaccineImmune SurveillanceT Cell ImmunityCd4 T Cell ResponsesImmunomodulationImmunotherapeuticsDendritic Cell BiologyImmunotherapyMedicineRadiation OncologyDendritic Cells